Jiankun Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiankun Xu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Hao Hu
Department of Gastroenterology Shuguang Hospital, Shanghai University of Traditional Chinese Medicine Shanghai China
1 shared publication - Jin Geng
Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
1 shared publication - Qi Xing
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518059, China
1 shared publication - Shanmeng Lin
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518059, China
1 shared publication
Latest Publications
- Open Access
Tumor-Targeting Polymer–Drug Conjugate for Liver Cancer Treatment In Vitro
Bufalin (buf) has poor solubility in aqueous solution, poor tumor targeting, and many non-specific toxic and side effects. The advantages of high-molecular-weight polymer conjugates are that they can improve the water solubility of buf, prolong plasma half-life, and reduce non-specific toxicity. A novel water-soluble polymer–drug conjugate with buf and fluorescein pendants was prepared by the combination of reversible addition-fragmentation transfer (RAFT) polymerization and click chemistry. Its anticancer performance and cellular uptake behavior against liver cancer were investigated in vitro. The polymer–buf conjugates exhibit controlled release and tumor-targeting capabilities, showing promise for clinical applications.
Open AccessTumor-Targeting Polymer–Drug Conjugate for Liver Cancer Treatment In Vitro
Bufalin (buf) has poor solubility in aqueous solution, poor tumor targeting, and many non-specific toxic and side effects. The advantages of high-molecular-weight polymer conjugates are that they can improve the water solubility of buf, prolong plasma half-life, and reduce non-specific toxicity. A novel water-soluble polymer–drug conjugate with buf and fluorescein pendants was prepared by the combination of reversible addition-fragmentation transfer (RAFT) polymerization and click chemistry. Its anticancer performance and cellular uptake behavior against liver cancer were investigated in vitro. The polymer–buf conjugates exhibit controlled release and tumor-targeting capabilities, showing promise for clinical applications.